Have done 1 cycle of chemotherapy with oxaliplatin +capacetibine for stage 4 colon cancer .spread to segment 5 of
liver and lymphnodes.Biomarker tests shows Nras and kras mutations as wild type and braf v600e mutation as positive.
After seeing the reports again continued the same chemo of oxaliplatin+capacetibine as first line of trwatment.
Is targeted therapy not work for above gene mutations.
If helps when it can be started.
Please suggest